Models of good practice in drug treatment in Europe. Project group
|
|
- Archibald Simmons
- 5 years ago
- Views:
Transcription
1 Models of good practice in drug treatment in Europe ( moretreat ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008
2 Objectives and Tasks To encourage drug treatment strategies which enable to reach substance users on an earlier stage of their addiction career to improve their integration and health Identify, collect and evaluate models of good practice in drug treatment in Europe Formulation of good practice guidelines for key interventions in drug treatment Carry out an inventory of effectiveness of drug treatment Evidence based recommendations for central drug treatment modalities Improve the quality of drug treatment services in the EU-Member States Exchange of good practices in drug treatment was supported Based on consensus process
3 What has been done European inventory of good practice of drug treatment interventions and their effectiveness based on Scientific reviews of international and European (published in English) evidence Regional search for most relevant studies - realised by the partners resulted in Development of European evidence-based guidelines for good practice with respect to different drug treatment interventions/modalities
4 Evidence-based guidelines for key interventions Dimensions approach, context, duration, staff, client groups, eligibility, inclusion and exclusion criteria, treatment access to service, referral pathways, integrated care pathways Standards management standards, commissioning standards, responsibilities, performance/outcome monitoring, seamless provision of services and support from one setting to the other (e.g. community prisons/hospitals, psychiatry), care coordination, departure planning, monitoring Assessment process-management, phases of treatment, performance/outcome monitoring
5 Guidelines for key interventions in drug treatment Enhancing motivation for change Maintenance treatment Detoxification Cross-cutting issues Treatment for clients with co-occurring disorders Interventions in blood-borne diseases Drug treatment Treatment in criminal justice sys. Treatment for stimulant use disorders Pregnancy and parenting Systemic aspects of treatment Brief interventions therapies Psychosocial interventions
6 Main findings on effectiveness - in brief Motivational Enhancement Therapy Especially good outcomes at early stages of treatment MI seems to increase the effect of another treatment Psychosocial interventions Have an effect on drug dependence - no form of psychosocial treatment works better than another Psychosocial treatment usually improves substitution maintenance treatment outcomes Maintenance treatment Methadone is the best-studied and most effective opioid agonist Treatment outcome is improved with increased dosages and the provision of adequate psychosocial support Detoxification Methadone with equal dose decrease is the standard detoxification Efficacy of buphrenorphine is comparable to methadone
7 Main findings on effectiveness - in brief Brief interventions (one or more sessions to reduce individual harm) High efficacy for cognitive-behavioural therapy, positive effects of family and social therapies Mostly concentrated on problem use of cannabis and stimulants Treatment in criminal justice system All community services can be offered in prison (medical and drug-free treatment as well as harm reduction) Combination of prison-treatment and continuity of care after release is most effective Treatment for co-occurring disorders Three types of interventions are probably effective: Group counselling, contingency management, long-term residential treatment Treatment for stimulant use Limited evidence available shows that most patients can be effectively treated in intensive outpatient programmes There is no evidence for prescribing antidepressants
8 Effectiveness of Harm Reduction Needle and syringe exchange services Strong evidence that availability of NSP contributes to the control of HIV among IDUs May be effective in reducing drug use frequency, transition from i.v. to smoking Drug consumption rooms Positive outcome on health status + risk behavior (reduction of drug-related deaths) Improve enrolment and retention in drug treatment Testing and vaccination No clear evidence for effectiveness of testing for blood-borne diseases Vaccination against hepatitis B is strongly effective in preventing hepatitis B infection HBV vaccination seems to have a positive influence on the hepatitis C serostatus Information and education Only few studies: most effective in combination with other prevention strategies On the short-term in may be effective in raising awareness for risks All interventions are less effective in preventing hepatitis C infection
9 Summary There is a wide range of different drug treatment interventions (concepts, methods, aims) Not all interventions delivered in Europe have shown to be effective Three main types of interventions Pharmacological treatment aim at reduction or cessation of opioid use Maintenance treatment shows better outcome than detoxification Reduction of illicit drug use and crime, decrease of mortality Psychosocial interventions aim at motivation to change drug use and risk behaviour CBT and MI often focused on cocaine/cannabis users or young drug users Coping with risk-situations, reduction of drug use Harm reduction aim at control or reduction of blood-borne diseases NSP programmes, drug consumption rooms, vaccination addressed to IDUs Decrease of sharing of drug use equipment, prevention of overdoses
10 Conclusions situation in Europe Most available literature exists for medical treatment Detoxification and maintenance treatment with different substances (especially methadone, buphrenorphine and heroin) Despite: Out 148 studies only 56 are from Europe (38%) Followed by psychosocial interventions Problem: Many different study designs for different approaches made it difficult to compare the outcomes Out of 102 studies 29 are from Europe (28%) - Most studies are from USA and Australia Harm-reduction Evidence for effectiveness of harm-reduction is in general rather scarce Studies focus on relation between service utilisation and the reduction of blood-borne infections and risk behaviour
Substance use and misuse
An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes
More informationThe available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs
More informationOST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success
XVIII International AIDS Conference, 2010 Vienna UNODC-GTZ Satellite Symposium: OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success Joerg
More informationStrategies of drug users to avoid infection with hepatitis C
With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike
More informationTechnical Guidance Note for Global Fund HIV Proposals
Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United
More informationShould buprenorphine be covered for maintenance treatment in opioid dependent persons?
Prepared by: Silvia Pregno May 13,2012 Patients: people with opioid dependence Should buprenorphine be covered for maintenance treatment in opioid dependent persons? Intervention: buprenorphine Comparison:
More informationHIV in Prison Situation in Frankfurt am Main
HIV in Prison Situation in Frankfurt am Main European Project ROME-SEMINAR, May 14.-15., 2008 Horst Herkommer, Sella Oneko Praxis Psychosoziale Beratung Frankfurt am Main Germany General remark: Situation
More informationExploring Barriers & Solutions in Facilitating Detox
Exploring Barriers & Solutions in Facilitating Detox Dr Brion Sweeney 8 th April 2008 Background Everyone is an expert Abstinence Based Programmes Harm Reduction Approaches Remissions, Relapses and Interventions
More informationHA Corporate Scholarship Program:
HA Corporate Scholarship Program: Substance Abuse Service in Psychiatry Ronnie Pao 02-10-10 The Maudsley Hospital Marina House Community Drug & Alcohol Team London Borough of Southwark Provides a Tier
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationPromoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification
More informationThe impact of economic recession on drug users and drug treatment
The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry
More informationDrug treatment and prevention in Tartu prison. Maret Miljan Department of Prisons Ministry of Justice Estonia
Drug treatment and prevention in Tartu prison Maret Miljan Department of Prisons Ministry of Justice Estonia Prisons in Estonia 3470 prisoners (25.05.2010): 2768 convicted 702 held under custody 5 prisons:
More informationGLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
More informationStrategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations
cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,
More informationKAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA
KAZAKHSTAN Territory : 2,717,300 km 2 Capital: Astana Map No. 3771 Rev. 6 UNITED NATIONS January 2004 BASIC DATA Total population (millions) 2009 15.5* Population under age15 (as % of total) 2010 23.8*
More informationPrevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies
Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationORGANIZATION OF AMERICAN STATES
ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic
More informationOpioid Withdrawal, Opioid Substitution, and HIV Infection
Opioid Withdrawal, Opioid Substitution, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University New Haven, Connecticut Learning Objectives After attending
More informationThe effectiveness of interventions related to the use of illicit drugs: prevention, harm reduction, treatment and recovery. A review of reviews
The effectiveness of interventions related to the use of illicit drugs: prevention, harm reduction, treatment and recovery. A review s Item type Authors Publisher Report; Systematic Review Bates, Geoff;
More informationHIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
More informationThe Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC
The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections
More informationWHAT IS HARM REDUCTION?
HARM REDUCTION WHAT IS HARM REDUCTION? Harm reduction is defined as, an umbrella term for interventions aiming to reduce the problematic effects of behaviors. Originally and frequently associated with
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification
More informationAs a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14
More informationPH52. Audit tool for the implementation of. NICE public health guidance 52 Needle and syringe programmes
PH52 Audit tool for the implementation of NICE public health guidance 52 Needle and syringe programmes Introduction This audit tool has been developed to help you audit implementation of, and compliance
More informationSubstance Abuse Suboxone Treatment
Substance Abuse Suboxone Treatment Program Waterbury Hospital Infectious Disease Clinic Richard Smith, LCSW Leonard Savage, Consumer Steven I. Aronin, MD FACP, Program Director Ryan White All Grantee Meeting
More informationPrevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs
Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject
More informationHARM REDUCTION & TREATMENT. Devin Reaves MSW
HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that
More informationAs a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More informationOpioid Withdrawal, Opioid Substitution Treatment, and HIV Infection
Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University Chief of Medicine Cornell Scott-Hill Health Center
More informationMethadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies
Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationPoland nationalupdate
Poland nationalupdate 16th October 2014 Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) Estimation of HIV and HCV prevalence among injecting drug users in
More informationANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)
ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total
More informationState Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment
State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment DEPARTMENT OF HUMAN SERVICES (DHS) DIVISION OF MENTAL HEALTH & ADDICTION SERVICES (DMHAS) STORI INFORMATIONAL WEBINAR
More informationChad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next
Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery Drug Policy, Harm Reduction, and What s Next The start or lack thereof of Drug Policy in the United States The Harrison Narcotics
More informationNote: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.
Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting
More informationMedical Director. and in prison settings in Romania. Ministry of Justice National Administration of Penitentiaries L IŢ
Dr. Geta Cucu edical Director Romanian National Administration of Penitentiaries Dr. ihai Corciova Expert UNODC Project - HIV/AIDS prevention and care among IDUs and in prison settings in Romania inistry
More informationHow Can Injectable Hydromorphone and Pharmaceutical-Grade Heroin be Used to Treat Opioid Use Disorder?
How Can Injectable Hydromorphone 0 and Pharmaceutical-Grade Heroin be Used to Treat Opioid Use Disorder? Dr. Eugenia Oviedo-Joekes University of British Columbia Dr. Martin Schechter University of British
More information26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1
The 16 th Core Group Meeting of the TB/HIV Working Group 26 28 May 2010, Almaty, Kazkhstan Nina Kerimi UNODC Regional Project Coordinator 1 UNODC Regional Office for Central Asia covers 6 countries: AZE,
More informationBuilding capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
More informationNHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification
NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) Rationale General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification Aims It is the responsibility of general practitioners
More informationBROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.
13. Substance Misuse Introduction Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. The term substance misuse often refers to illegal drugs, but, some
More informationAddiction and Substance misuse pathways
Addiction and Substance misuse pathways Gordon Morse Chief Medical Officer Turning Point UK Gordon Morse statement of interests Sole employer Turning Point Some unpaid advisory work to the Hepatitis C
More informationDrug demand reduction and harm reduction: complementary approaches. Gilberto Gerra Chief Global Challenges Section Division for Operations
Drug demand reduction and harm reduction: complementary approaches Gilberto Gerra Chief Global Challenges Section Division for Operations The comprehensive approach: no contrast, but synergism, between
More informationEMCDDA-update HIV/HCV among people who inject drugs: situation and response
EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis
More informationBuprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008
Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality
More informationDrug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate
Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate What is a DCR? A facility that allows people to inject/smoke illicitly purchased drugs,
More informationIntervention from the World Health Organization
Thematic discussion on the implementation of the UNGASS outcome document Operational recommendations on Demand reduction and related measures, including prevention and treatment, as well as other health-related
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationPERSPECTIVES ON DRUGS Characteristics of frequent and high-risk cannabis users
European Monitoring Centre for Drugs and Drug Addiction UPDATED 28. 5. 2013 PERSPECTIVES ON DRUGS Characteristics of frequent and high-risk cannabis users Cannabis is Europe s most commonly used illicit
More informationGuidelines For Services Providing Injecting Equipment
Guidelines For Services Providing Injecting Equipment Best Practice Recommendations For Commissioners and Injecting Equipment Provision (IEP) Services in Scotland (Scottish Government 2010) January 2014
More informationStatement by the Portuguese Deputy Minister for Health. Vienna, 8 March 2010
Statement by the Portuguese Deputy Minister for Health 53 nd Session of the Commission on Narcotic Drugs Vienna, 8 March 2010 Mr. Chairman, Distinguished Delegates, Ladies and Gentlemen, First, I would
More informationThis document was generated by the Reference Group to the United Nations on HIV and Injecting Drug Use.
This document was generated by the Group to the United Nations on HIV and Injecting Drug Use. The data included in this report reflect the results of a systematic search and review of data on a range of
More informationShould Methadone and/or Buprenorphine be included in the WHO Model List of Essential Medicines? Reviewing evidence from Iranian experience.
Should Methadone and/or Buprenorphine be included in the WHO Model List of Essential Medicines? Reviewing evidence from Iranian experience. MT Yasamy, MD * Essential drugs are those that satisfy the health
More informationConor K Farren. St Patricks University Hospital Trinity College Dublin Ireland
Conor K Farren St Patricks University Hospital Trinity College Dublin Ireland NICE: Background NICE set up in 1999 to reduce variation in availability and quality of NHS treatments. Does this by: Evidence
More informationJSNA Substance Misuse
JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour
More informationWhat is harm reduction?
What is harm reduction? The International Harm Reduction Association (IHRA) defines harm reduction as the policies, programmes and practices that aim to reduce the harms associated with the use of psychoactive
More informationDiversion, misuse and trafficking of methadone and buprenorphine: Impact on recovery
Diversion, misuse and trafficking of methadone and buprenorphine: Impact on recovery Hannu Alho, Ph.D., M.D. Professor of Addiction Medicine, University of Helsinki Research Professor, National Institute
More informationCocaine users: a special population? The evidence for policy and practice. SSA Conference 2005 Luke Mitcheson, South London and Maudsley NHS Trust
Cocaine users: a special population? The evidence for policy and practice SSA Conference 2005 Luke Mitcheson, South London and Maudsley NHS Trust Why might cocaine users be a Different drug? special population?
More informationNational Guidelines. Interim methadone prescribing
National Guidelines Interim methadone prescribing 2007 National Guidelines Interim methadone prescribing Citation: Ministry of Health. 2007. National Guidelines: Interim methadone prescribing. Wellington:
More informationNSPs in Estonia: current situation and future challenges
NSPs in Estonia: current situation and future challenges Aljona Kurbatova National Institute for Health Development Riga, 25.10.2010 1 Background First NSP project was launched in May 1997 needle and syringe
More informationManaging drug misuse in pregnancy and beyond
Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management
More informationInjecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration
Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration Alexander Grabenhofer-Eggerth TDI expert meeting - Lisbon,
More informationHepatitis prevention in the context of HIV prevention point work in Latvia
Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205. HIV prevention point network in Latvia: History; Location;
More informationHistorical Perspectives
Why Harm Reduction? 1 Rochelle Head-Dunham, MD FAPA Executive Director and Medical Director Metropolitan Human Services District Clinical Associate Professor of Psychiatry LSU and Tulane Historical Perspectives
More informationMethadone Diversion: Why it happens, what the illicit market looks like and the implications
Methadone Diversion: Why it happens, what the illicit market looks like and the implications Paul Duffy & Helen Baldwin Centre for Public Health Liverpool John Moores University Methadone provision and
More informationHARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 UNIVERSITY OF UTAH HEALTH, 2018
HARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 OBJECTIVES Define Harm reduction. Understand how harm reduction theory is applied clinically. Explore how to analyze the spectrum of Harm Reduction
More informationThe Misuse of Opiate Substitution Therapy: an Obstacle for the Diffusion of Best Practice in Italy Lisbon, 23 September 2015
+ Felice Nava, MD, PhD Director Penitentiary Medicine Padua, Italy Vice-President Italian Society of Addiction Medicine The Misuse of Opiate Substitution Therapy: an Obstacle for the Diffusion of Best
More informationScientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances
page 1/5 Scientific Facts on Psychoactive Drugs Tobacco, Alcohol, and Illicit Substances Source document: WHO (2004) Summary & Details: GreenFacts Context - Psychoactive drugs such as tobacco, alcohol,
More informationPREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES
PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES Background In Wisconsin the two primary modes of HIV transmission are unsafe sexual behavior and nonsterile injection practices. More
More informationEuropean Legal Database on Drugs
European Legal Database on Drugs / Reviewing legal aspects of substitution treatment at international level Prepared by the EMCDDA at the request of the Pompidou Group Secretariat EMCDDA ELDD Comparative
More informationHIV AND PEOPLE WHO INJECT DRUGS
UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
More informationFamily Health Centers of San Diego Alcohol and Other Drug Services
Family Health Centers of San Diego Alcohol and Other Drug Services Today s Topics What is Substance Use Disorder? What is Harm Reduction? Adult Treatment Options Family Health Centers of San Diego Alcohol
More informationThe role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
More informationPart 1: Introduction & Overview
Part 1: Introduction & Overview We envision a collaborative, participative partnership around IDU that: Provides all relevant and interested stakeholders with a voice and role. Promotes awareness of the
More informationDr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia
Dr. dr. Diah Setia Utami, SpKJ, MARS Deputy of Rehabilitation Narcotic National Board of Republic of Indonesia Growing evidence in changing of usage, from natural plant substances to synthetic substances
More informationBackground. Population/Intervention(s)/ Comparison/Outcome(s) (PICO)
updated 2012 Role of sterile injection equipment and outreach programmes for injecting drug users Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related
More informationCROATIA. Venija Cerovecki, MD, GP. University of Zagreb School of Medicine Department for Family Medicine
CROATIA Experiences and issues in the management of drug, health and social co-morbidities among clients in opioid substitution treatment (OST) with GPs Venija Cerovecki, MD, GP University of Zagreb School
More informationPublic drug policies Catalonia
Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia
More informationStatistics from the Northern Ireland Drug Misuse Database: 1 April March 2011
Statistics from the Northern Ireland Drug Misuse Database: 1 April 2010 31 March 2011 This bulletin summarises information on people presenting to services with problem drug misuse and relates to the 12-month
More informationHarms and harm reduction workbook. Country X
Harms and harm reduction workbook Country X 1 Table of Contents T0. Summary... 3 T1. National profile... 3 T1.1 Drug-related deaths... 3 T1.2 Drug related acute emergencies... 4 T1.3 Drug related infectious
More informationOpioid Withdrawal, Opioid Substitution, and HIV Infection
Opioid Withdrawal, Opioid Substitution, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University New Haven, Connecticut Learning Objectives After attending
More informationPrimary Health Networks
Primary Health Networks Drug and Alcohol Treatment Activity Work Plan 2016-17 to 2018-19 Hunter New England & Central Coast Please note: This Activity Work Plan was developed in response to the HNECC PHN
More informationCOUNTRY TABLE. MONTENEGRO.
EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI
More informationSigns of success latest national NESI data?
Needle Exchange Surveillance Initiative Signs of success latest national NESI data? Alison Munro (University of the West of Scotland) Study partners Professor Avril Taylor Chief Investigator (UWS) Dr Alison
More informationManagement Options for Opioid Dependence:
Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice
More informationHarm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD
Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD Objectives Provide an overview of harm reduction by defining shared language and key terms. Collaboratively
More informationHarm Reduction Database Wales: Needle and Syringe provision
Harm Reduction Database Wales: Needle and Syringe provision 2012-13 Public Health Wales would like to thank all those that contributed to the Harm Reduction Database Wales: NSP service users, NSP staff
More informationInfectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with
Infectious and Communicable Diseases Prevention and Control Program Annual Service Plan A. Community Need and Priorities We are situated rurally with no access to walk in clinics and access to health care
More informationTrigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!
More informationService Specification: Bristol and South Gloucestershire Specialist Substance Misuse Treatment Service January 2016
This specification is an annex to the Service Specification for the provision of Child and Adolescent Mental Health Services. It must be read along with the overarching specification which applies to all
More informationJerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry
Jerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry Acknowledgements Funding for this work has come from: The Staunton Farm Foundation
More informationDrug Misuse Research Division
Drug Misuse Research Division Contents Occasional Paper p No. 12/ 9/ 2003 2004 Trends in treated problem drug use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to
More informationThe evolution of the HIV/AIDS outbreak among IDUs in Romania
The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU
More information